Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Obesity Surgery

01-05-2012 | Guidelines

IFSO-APC Consensus Statements 2011

Published in: Obesity Surgery | Issue 5/2012

Login to get access

Abstract

Associations of BMI with body composition and health outcomes may differ between Asian and European populations. Asian populations have also been shown to have an elevated risk of type 2 diabetes, hypertension, and hyperlipidemia at a relatively low level of BMI. New surgical indication for Asian patients should be discussed by the expert of this field. Forty-four bariatric experts in Asia-Pacific and other regions were chosen to have a voting privilege for IFSO-APC Consensus at the 2nd IFSO-APC Congress. A computerized audience-response voting system was used to analyze the agreement with the sentence of the consensus. Of all delegates, 95% agreed with the necessity of the establishment of IFSO-APC consensus statements, and 98% agreed with the necessity of a new indication for Asian patients.
IFSO-APC Consensus statements 2011
  • Bariatric surgery should be considered for the treatment of obesity for acceptable Asian candidates with BMI ≥ 35 with or without co-morbidities
  • Bariatric/GI metabolic surgery should be considered for the treatment of T2DM or metabolic syndrome for patients who are inadequately controlled by lifestyle alternations and medical treatment for acceptable Asian candidates with BMI ≥ 30
  • The surgical approach may be considered as a non-primary alternative to treat inadequately controlled T2DM, or metabolic syndrome, for suitable Asian candidates with BMI ≥ 27.5.
Other eight sentences are agreed with by majority of the voting delegates to form IFSO-APC consensus statements. This will help to make safe and wholesome the progress of bariatric and metabolic surgery in Asia.
Literature
1.
2.
3.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef
4.
NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61.
5.
Lakdawara M, Bhasker A, Asian Consensus meeting on Metabolic Surgery (ACMOMS), Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population: August 9th and 10th, 2008, Trivandrum, India. Obes Surg. 2010;20(7):929–36.CrossRef
6.
7.
Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399–405.PubMedCrossRef
8.
Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368(9548):1681–8.PubMedCrossRef
9.
Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2008. J Am Med Assoc. 2010;303(3):235–41.CrossRef
10.
Griffiths PL, Bentley ME. The nutrition transition is underway in India. J Nutr. 2001;131(10):2692–700.PubMed
11.
International Diabetes Federation, Diabetes Atlas, 4th edition, 2009.
12.
Ramachandran A, Snehalatha C, Vijay V. Temporal changes in prevalence of type 2 diabetes and impaired glucose tolerance in urban southern India. Diabetes Res Clin Pract. 2002;58(1):55–60.PubMedCrossRef
13.
Parizkova J, Chin MK, Chia M, et al. An international perspective on obesity, health and physical activity: current trends and challenges in China and Asia. J of Exerc Sci and Fit. 2007;5(1):7–23.
14.
15.
Ramachandran A, Snehalatha C, Kapur A, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44(9):1094–101.PubMedCrossRef
16.
Snehalatha C, Viswanathan V, Ramachandran A. Cut-off values for normal anthropometric variables in Asian Indian adults. Diabetes Care. 2003;26(5):1380–4.PubMedCrossRef
17.
Misra A, Pandey RM, Devi JR, et al. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes. 2001;25(11):1722–9.CrossRef
18.
Chandalia M, Abate N, Garg A, et al. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metabol. 1999;84(7):2329–35.CrossRef
19.
Report of WHO Consultation, “Obesity: preventing and managing the global epidemic,” World Health Organization—Technical Report Series, no. 894, pp. 1–253, 2000.
20.
Alberti KGMM, Zimmet P, Shaw J, et al. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–80.PubMedCrossRef
21.
22.
Raji A, Seely EW, Arky RA, et al. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metabol. 2001;86(11):5366–71.CrossRef
23.
Yajnik CS, Lubree HG, Rege SS, et al. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metabol. 2002;87(12):5575–80.CrossRef
24.
Gill T. Young people with diabetes and obesity in Asia: a growing epidemic. Diabetes Voice. 2007;52:20–2.
25.
Ramachandran A, Snehalatha C, Yamuna A, et al. Insulin resistance and clustering of cardiometabolic risk factors in urban teenagers in Southern India. Diabetes Care. 2007;30(7):1828–33.PubMedCrossRef
26.
Zheng W, McLerran DF, Rolland B, et al. Association between body mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364(8):719–29.PubMedCrossRef
27.
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.PubMedCrossRef
28.
International Diabetes Federation. Diabetes Atlas. 3rd ed. Brussels: International Diabetes Federation; 2006.
29.
Chan JCN, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–40.PubMedCrossRef
30.
Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia. 2003;46(9):1190–8.PubMedCrossRef
31.
Jia WP, Pang C, Chen L, et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia. 2007;50(2):286–92.PubMedCrossRef
32.
Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract. 2006;73(2):126–34.PubMedCrossRef
33.
Ramachandran A. Epidemiology of diabetes in India—three decades of research. J Assoc Physicians India. 2005;53:34–8.PubMed
34.
Ramachandran A, Mary S, Yamuna A, et al. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care. 2008;31(5):893–8.PubMedCrossRef
35.
Huxley R, James WP, Barzi F, et al. Obesity in Asia Collaboration. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;9 suppl 1:53–61.PubMedCrossRef
36.
Aekplakorn W, Bunnag P, Woodward M, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care. 2006;29(8):1872–7.PubMedCrossRef
37.
Ma RCW, Ko GT, Chan JC. Health hazards of obesity—an overview. In: Williams G, Frubeck G, editors. Obesity: Science to Practice. Hoboken: John Wiley & Sons; 2009. p. 215–36.
38.
Nakagami T, Qiao Q, Carstensen B, et al. Age, body mass index and type 2 diabetes—associations modified by ethnicity. Diabetologia. 2003;46(8):1063–70.PubMedCrossRef
39.
Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev. 2002;3(3):141–6.PubMedCrossRef
40.
Reynolds K, Gu D, Whelton PK, et al. Prevalence and risk factors of overweight and obesity in China. Obesity (Silver Spring). 2007;15(1):10–8.CrossRef
41.
Balkau B, Deanfield JE, Despres JP, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardio- vascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007;116(17):1942–51.PubMedCrossRef
42.
Lear SA, Humphries KH, Kohli S, et al. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr. 2007;86(2):353–9.PubMed
43.
Liu KH, Chan Y, Chan W, et al. Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intimamedia thickness. Diabetes Care. 2006;29(2):379–84.PubMedCrossRef
44.
Cheung BM, Wat NM, Man YB, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007;30(6):1430–6.PubMedCrossRef
45.
Mak KH, Ma S, Heng D, et al. Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events. Am J Cardiol. 2007;100(2):227–33.PubMedCrossRef
46.
Thomas GN, Schooling CM, McGhee SM, et al. Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol (Oxf). 2007;66(5):666–71.CrossRef
47.
Zhang X, Shu XO, Yang G, et al. Abdominal adiposity and mortality in Chinese women. Arch Intern Med. 2007;167(9):886–92.PubMedCrossRef
48.
Kadowaki T, Miyake Y, Hagura R, et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia. 1984;26(1):44–9.PubMedCrossRef
49.
Fukushima M, Usami M, Ikeda M, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism. 2004;53(7):831–5.PubMedCrossRef
50.
Kuroe A, Fukushima M, Usami M, et al. Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance. Diabetes Res Clin Pract. 2003;59(1):71–7.PubMedCrossRef
51.
Chan WB, Tong PCY, Chow CC, et al. The associations of body mass index, C peptide and metabolic status in Chinese type 2 diabetic patients. Diabet Med. 2004;21(4):349–53.PubMedCrossRef
52.
Boyko EJ, Fujimoto WY, Leonetti DL, et al. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care. 2000;23(4):465–71.PubMedCrossRef
53.
Veena SR, Geetha S, Leary SD, et al. Relationships of maternal and paternal birthweights to features of the metabolic syndrome in adult offspring: an inter-generational study in South India. Diabetologia. 2007;50(1):43–54.PubMedCrossRef
54.
Karter AJ, Ferrara A, Liu J, et al. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287(19):2519–27.PubMedCrossRef
55.
Yokoyama H, Okudaira M, Otani T, et al. High incidence of diabetic nephropathy in early onset Japanese NIDDM patients: risk analysis. Diabetes Care. 1998;21(7):1080–5.PubMedCrossRef
56.
Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med. 2011;28(6):628–42.PubMedCrossRef
57.
2004 ASBS Consensus Conference on Surgery for Severe Obesity. Surg Obes Relat Dis. 2005;1(3):297–381.CrossRef
58.
Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2010;6(1):1–5.CrossRef
59.
Kasama K, Seki Y, Tagaya N, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009;19(10):1341–5.PubMedCrossRef
60.
Kumar KV, Ugale S, Gupta N, et al. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther. 2009;11(12):785–9.PubMedCrossRef
61.
Huang CK, Lo CH, Shabbir A, et al. Novel bariatric technology: laparoscopic adjustable gastric banded plication: technique and preliminary results. Surg Obes Relat Dis. 2011;8:41–5.PubMedCrossRef
Metadata
Title
IFSO-APC Consensus Statements 2011
Publication date
01-05-2012
Published in
Obesity Surgery / Issue 5/2012
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-012-0610-7